Document is current
Any future updates will be listed below
-
Authors
Shigayeva, Altynay
Kandel, Christopher
Farooqi, Lubna
Zhong, Zoe
Gingras, Anne-Claude
Coleman, Brenda L.
Gilbert, Lois
Gold, Wayne L.
Major, Maria
Mazzulli, Tony
Mubareka, Samira
Vojicic, Jelena
Yang, Jingyan
Zhang, Pingping
Martin, Catherine
Kyaw, Moe H.
McLaughlin, John M.
McGeer, Allison
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 9 December 2024
First Online: 8 February 2025
Declarations
:
: Informed consent was obtained from all study participants. The study was approved by the research ethics boards of participating hospitals (North York General #2024-0233-1025; Sunnybrook Health Sciences Centre #149–1994; Michael Garron Hospital #084-0209-Lab-01, University Health Network #14-8339-AE, The Scarborough Health Network #MED-02-011, William Osler Health System #95 − 0001, and Mount Sinai Hospital #21-0069-E).
: Not applicable.
: MHK, CM, MM, PZ, JV, JY and JMM are employees and shareholders of Pfizer Inc. AM declares grants and personal fees from Pfizer, grants from Sanofi, personal fees from AstraZeneca, GlaxoSmithKline, Moderna and Novavax, outside the submitted work. ACG has received research funds from Providence Therapeutics Holdings, Inc., outside the submitted work. All other authors, no conflicts of interest.
